Reminder: Welcome to Elekta’s Capital Markets Presentation at ASTRO (Cision)
STOCKHOLM, September 13 – Elekta (EKTA-B.ST) welcomes you to its Capital Markets Presentation on September 26, 2016, in conjunction with the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO), in Boston, USA.
The event will be held on Monday, September 26, at 09:00 – 11:30 a.m., at Renaissance Boston Waterfront. Speakers at the event will be Richard Hausmann, Elekta’s President and CEO, and other members of Elekta’s management team. To attend, please register via https://www.elekta.com/investors/cmd-registration/index.php as soon as possible, but no later than September 15. It will also be possible to listen in to the Capital Markets Presentation via the web. Please note that we only will be able to take questions from the participants on location in Boston. Details for the conference call will be published at Elekta's webpage (www.elekta.com/investors) prior to the meeting. During ASTRO, Elekta will also host Users meeting on Saturday September 24. For more information about Users meeting and in order to register for the event, please use the following link: http://www.cvent.com/events/2016-elekta-user-meeting/event-summary-225b67b7eafa4bd58e6b07b3d6d52f10.aspx We look forward to your participation on September 26. Best regards, Johan Andersson Director Investor Relations Tobias Bülow Director Financial Communication Frida Johansson Investor Relations # # # For further information, please contact: Frida Johansson, Investor Relations, Elekta AB (publ) Tel: +46 70 866 76 74, e-mail: Frida.Johansson@elekta.com Time zone: CET: Central European Time About Elekta Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives. Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com.